Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination

(Natural News) It has come to our attention that a second participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trials has come down with a serious neurological condition that the company claims is not at all related to the volunteer getting vaccinated. Just like the first participant, who we reported developed severe spinal inflammation, this second...